Rational Dispersion for the Introduction of Transcatheter Mitral Valve Repair Into Clinical Practice: Lessons Learned From TAVR.
暂无分享,去创建一个
[1] M. Mack,et al. Transcatheter Mitral‐Valve Repair in Patients with Heart Failure , 2018, The New England journal of medicine.
[2] D. Maucort-Boulch,et al. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation , 2018, The New England journal of medicine.
[3] A. Sannino,et al. Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation: A Systematic Review and Meta-analysis , 2017, JAMA cardiology.
[4] L. Fleisher,et al. 2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2017, Journal of the American College of Cardiology.
[5] Danica Marinac-Dabic,et al. The STS-ACC transcatheter valve therapy national registry: a new partnership and infrastructure for the introduction and surveillance of medical devices and therapies. , 2013, Journal of the American College of Cardiology.
[6] M. Mack,et al. Rational dispersion for the introduction of transcatheter valve therapy. , 2011, JAMA.
[7] Saibal Kar,et al. Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.